Differential surface density and modulatory effects of presynaptic GABAB receptors in hippocampal cholecystokinin and parvalbumin basket cells by Booker, Sam A. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Differential surface density and modulatory effects of
presynaptic GABAB receptors in hippocampal cholecystokinin
and parvalbumin basket cells
Citation for published version:
Booker, SA, Althof, D, Degro, CE, Watanabe, M, Kulik, Á & Vida, I 2017, 'Differential surface density and
modulatory effects of presynaptic GABAB receptors in hippocampal cholecystokinin and parvalbumin basket
cells', Brain Structure and Function . https://doi.org/10.1007/s00429-017-1427-x
Digital Object Identifier (DOI):
10.1007/s00429-017-1427-x
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Brain Structure and Function
Publisher Rights Statement:
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in
any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
ORIGINAL ARTICLE
Differential surface density and modulatory effects of presynaptic
GABAB receptors in hippocampal cholecystokinin
and parvalbumin basket cells
Sam A. Booker1,5 • Daniel Althof2 • Claudius E. Degro1 • Masahiko Watanabe3 •
A´kos Kulik2,4 • Imre Vida1
Received: 25 January 2017 / Accepted: 13 April 2017
 The Author(s) 2017. This article is an open access publication
Abstract The perisomatic domain of cortical neurons is
under the control of two major GABAergic inhibitory
interneuron types: regular-spiking cholecystokinin (CCK)
basket cells (BCs) and fast-spiking parvalbumin (PV) BCs.
CCK and PV BCs are different not only in their intrinsic
physiological, anatomical and molecular characteristics, but
also in their presynaptic modulation of their synaptic output.
Most GABAergic terminals are known to contain GABAB
receptors (GABABR), but their role in presynaptic inhibition
and surface expression have not been comparatively charac-
terized in the two BC types. To address this, we performed
whole-cell recordings from CCK and PV BCs and postsy-
naptic pyramidal cells (PCs), as well as freeze-fracture
replica-based quantitative immunogold electron microscopy
of their synapses in the rat hippocampal CA1 area. Our results
demonstrate that while both CCK and PV BCs contain func-
tional presynaptic GABABRs, their modulatory effects and
relative abundance are markedly different at these two
synapses: GABA release is dramatically inhibited by the
agonist baclofen at CCK BC synapses, whereas a moderate
reduction in inhibitory transmission is observed at PV BC
synapses. Furthermore, GABABR activation has divergent
effects on synaptic dynamics: paired-pulse depression (PPD)
is enhanced at CCK BC synapses, but abolished at PV BC
synapses. Consistent with the quantitative differences in
presynaptic inhibition, virtually all CCK BC terminals were
found to contain GABABRs at high densities, but only 40% of
PVBCaxon terminals containGABABRs at detectable levels.
These findings add to an increasing list of differences between
these two interneuron types, with implications for their net-
work functions.
Keywords Presynaptic inhibition  Synaptic transmission 
GABAergic interneurons  Short-term plasticity  Electron
microscope
Introduction
The perisomatic domain of cortical pyramidal cells (PC) is
under GABAergic control of a specific subset of inhibitory
interneurons called basket cells (BCs) (Buhl et al. 1994;
Freund and Buzsa´ki 1996; Klausberger and Somogyi 2008).
BCs are heterogeneous, comprising two main types with
distinct neurochemical and anatomical characteristics, which
are believed to underlie their divergent roles in functional
networks. The twoBC types are primarily distinguishedon the
basis of their selective expression of either the neuropeptide
cholecystokinin (CCK) or the calcium-binding protein
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parvalbumin (PV) (Nunzi et al. 1985; Kosaka et al. 1987;
Freund and Katona 2007; Lee and Soltesz 2011; Booker et al.
2013, 2017). Furthermore, CCK and PV BCs also differ in
their physiological properties,most prominently their regular-
versus fast-spiking discharge pattern, respectively.
Action potential-evoked release of GABA from inhibitory
terminals, including those of BCs, is dependent on reliable
activation of high voltage-gated calcium channels (VGCCs)
leading to vesicularGABA release,which is tightly controlled
by presynaptic neuromodulatory receptors for multiple
transmitter systems (Wu and Saggau 1995; Lu¨scher et al.
1997; Lee and Soltesz 2011). The two BC types show striking
differences in presynaptic mechanisms as well: in axon ter-
minals of CCK BCs Cav2.2 (N-type) VGCCs are localized to
the active zone, while in PV BCs Cav2.1 (P/Q-type) channels
are present (Hefft and Jonas 2005; Lee and Soltesz 2011).
Moreover, the compliment of presynaptic neuromodulatory
receptors also diverges: CCK BCs possess high levels of
endocannabinoid 1 receptors (CB1Rs),whilst PVBCspossess
muscarinic acetylcholine 2 (M2Rs) and l-opioid receptors
(Hajos et al. 1997; Katona et al. 1999; Fukudome et al. 2004;
Neu et al. 2007; Armstrong and Soltesz 2012; Lenkey et al.
2015). Despite these differences, both CCK and PV BCs
appear to express GABAB autoreceptors at their output
synapses (Lee and Soltesz 2011; Booker et al. 2013).
GABABRs are heterodimeric receptors composed of the
GABAB1 and GABAB2 subunits (Kaupmann et al. 1998).
At presynaptic membranes GABABRs comprise the Sushi-
domain containing GABAB1a splice variant (Guetg et al.
2009) and negatively couple to VGCCs via the G-protein
(Gi/o) bc subunit. Accordingly, activation of presynaptic
GABABRs by the canonical agonist baclofen has been
shown to result in a reduction of unitary IPSC amplitudes
at both CCK and PV BC synapses (Hefft et al. 2002; Lee
and Soltesz 2011; Booker et al. 2013; Jappy et al. 2016).
However, direct comparison is difficult due to large dif-
ferences in the concentration of agonist applied and
recording conditions in the individual studies. Furthermore,
the subcellular localization and density of the GABABRs in
synaptic and extrasynaptic membrane segments of CCK
and PV BC axon terminals has not yet been investigated.
In this study therefore we comparatively assessed the
function and localization of presynaptic GABABRs in
identified BC axon terminals, using whole-cell patch-clamp
recordings and quantitative SDS-digested freeze-fracture
replica (SDS-FRL) immunoelectron microscopy.
Materials and methods
Animals
All experiments were performed on 17–26-day-old rats,
wild-type or transgenic expressing Venus/yellow
fluorescence protein (YFP) under the vesicular GABA
transporter (vGAT) promoter, both on the Wistar back-
ground (Uematsu et al. 2008; Booker et al. 2014, 2017).
SDS-FRL electron microscopic analysis was performed on
60-day-old wild-type Wistar rats (2 rats). All experiments
were performed in accordance with institutional (Charite´-
Universita¨tmedizin Berlin; University of Freiburg, Frei-
burg, Germany), local (LaGeSo, Berlin, T 0215/11), and
national guidelines (German Animal Welfare Act; ASPA,
United Kingdom Home Office).
Acute slice preparation
Hippocampal slices were prepared as previously described
(Booker et al. 2014). Briefly, rats were decapitated, the
brain rapidly removed and placed in ice-cold carbogenated
(95% O2/5% CO2) sucrose-modified artificial cerebrospinal
fluid (in mM: 87 NaCl, 2.5 KCl, 25 NaHCO3, 1.25
NaH2PO4, 25 glucose, 75 sucrose, 7 MgCl2, 0.5 CaCl2, 1
Na-pyruvate, 1 Na-ascorbate). Transverse, 300 lm thick
slices were then cut on a Vibratome (VT1200 s, Leica,
Germany), stored submerged in sucrose-ACSF warmed to
35 C for 30 min and subsequently at room temperature
until the start of recording.
Whole-cell patch-clamp recordings
For whole-cell patch-clamp recordings, slices were trans-
ferred to a submerged recording chamber perfused with
carbogenated ACSF (in mM: 125 NaCl, 2.5 KCl, 25
NaHCO3, 1.25 NaH2PO4, 25 glucose, 1 MgCl2, 2 CaCl2, 1
Na-pyruvate, 1 Na-ascorbate) maintained at near physio-
logical temperatures (32 ± 1 C) with an inline heater
(SuperTech, Switzerland) at a high flow rate of
10–12 ml min-1. Slices were visualized with infrared dif-
ferential contrast illumination by means of an upright
microscope (BX-50, Olympus, Hamburg, Germany)
equipped with a 409 water-immersion objective (N.A.
0.8). BCs were pre-selected for recording based on vGAT-
Venus fluorescence, by means of epifluorescent illumina-
tion (480 nm), in large somata in and around str. pyrami-
dale and proximal str. radiatum. Whole-cell patch-clamp
recordings were accomplished using either an AxoPatch
200B or Multiclamp 700B amplifier (Molecular Devices,
USA). Recording pipettes were pulled from borosilicate
glass capillaries (2 mm outer/1 mm inner diameter, Hil-
genberg, Germany) on a horizontal electrode puller (P-97,
Sutter Instruments, CA, USA). When filled with intracel-
lular solution [composition in mM: 100 K-Gluc, 40 KCl, 2
MgCl2, 10 EGTA, 10 HEPES, 2 Na2-ATP, 0.3 Na2-GTP, 1
Na2-Creatinine, 0.1% biotinylated-lysine (Biocytin, Invit-
rogen, UK); pH: 7.4, Osmolarity: 280–300 mOsm] a pip-
ette resistance of 3–5 MX was achieved with a Cl- reversal
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potential (ER) of *30 mV. Unless otherwise stated, all
voltage-clamp recordings were performed at -65 mV and
all current-clamp recordings from the resting membrane
potential (VM). Throughout the recordings, the series
resistance was monitored, but not compensated. Signals
were filtered at 10 kHz using the built in 4-pole Bessel
filter of the amplifier, digitized at 20 kHz on an analog–
digital interface (CED 1401, Cambridge Instruments,
Cambridge, UK; or NI USB-6212 BNC, National Instru-
ments, Berkshire, UK), and acquired with WinWCP soft-
ware (courtesy of John Dempster, Strathclyde University,
Glasgow, UK; http://spider.science.strath.ac.uk/sipbs/soft
ware_ses.htm). Data was analyzed offline using the open
source Stimfit software package (Guzman et al. 2014).
Characterization of presynaptic GABABR function
Following breakthrough into whole-cell configuration,
intrinsic properties of recorded neurons were characterized
in current-clamp mode from resting VM. Neurons were
physiologically identified based on their response to hyper-
to depolarizing current steps (-500 to 500 pA, in 100 pA
steps, 500 ms duration). CCK BCs were identified as
responding to depolarizing stimulus with low to moderate
frequency trains of action potentials (APs); PV BCs were
identified as firing high-frequency non-accommodating
trains ([100 Hz) of APs. PCs showed characteristic large
amplitude and broad APs, and lower-frequency accom-
modating trains of APs. Neurons were rejected from further
analysis if VM was more depolarized than -50 mV, APs
did not overshoot 0 mV, or initial series resistance excee-
ded 30 MX or changed by[20% over the course of the
experiment.
Minimally stimulated monosynaptic inhibitory post-sy-
naptic currents (IPSC) in PCs were elicited in the presence
of NBQX (10 lM) and APV (50 lM) by extracellular
stimulation with a glass monopolar electrode (a patch
pipette filled with 2 M NaCl) placed in str. pyramidale at a
distance of 10–20 lm from the soma. IPSC were evoked
every 10 s with stimulus amplitudes of 1–20 V, minimally
exceeding threshold to evoke a response. A 5-min control
baseline was collected after which 1 lM WIN-55,212
(WIN) was briefly applied to the bath (2 min) to test
presynaptic CB1R sensitivity. Following washout of WIN
and recovery of IPSC amplitude to control levels (*5 min)
baclofen (10 lM) was applied to the bath and steady state
inhibition was observed at 3–5 min following wash in.
Following baclofen application, CGP-55,845 (CGP, 5 lM)
was applied to the bath confirming that the observed
responses were GABABR mediated. In recordings where
the IPSC was not sensitive to WIN application, we sub-
sequently applied the selective M2R agonist arecaidine
but-2-ynyl ester tosylate (ABET; 10 lM) (Chiang et al.
2010) to the bath to confirm that these WIN-insensitive
IPSCs were mediated by M2R-containing putative PV axon
terminals. In all recordings the whole-cell holding current
(IWC) in the CA1 PC was monitored to confirm successful
activation of postsynaptic GABABRs, given that presy-
naptic receptors show higher baclofen affinity (Dugladze
et al. 2013). Given the optimal voltage-clamp conditions
for the recording of perisomatic synaptic events meditated
by BCs, we did not block post-synaptic Kir3 potassium
channels in any of these experiments.
To confirm that presynaptic GABABR mediated effects
were specific to identified BCs, we performed paired
recordings between a CCK or PV BC and a CA1 PC.
Conditions were identical to those of single cell recordings
albeit with a lower 0.5 mM EGTA in the intracellular
solution (compensated by a higher K-gluconate content of
110 mM). Following characterization of intrinsic proper-
ties (see above) of pre- and postsynaptic neurons, 10 trains
of 10 APs (1–2 nA, 1 ms, 20 Hz) were elicited in the BC
while recording the CA1 PC in voltage-clamp (as above). If
a unitary synaptic connection was observed, seen as short-
latency (\4 ms) IPSCs in the PC following presynaptic
APs in averages of ten traces, it was assumed that there was
a direct synaptic connection. If synaptic connectivity was
not observed in the CA1 PC, the recording was abandoned,
an outside-out patch formed, and a neighboring CA1 PC
recorded. Once a synaptic connection was found we
recorded[50 traces under paired-pulse protocols (2 stimuli
with 50 ms interval), following which baclofen (10 lM)
was bath applied for 5 min, after which CGP (5 lM) was
bath applied. The IPSC amplitude was measured from the
preceding baseline as an average over a 0.4 ms window
corresponding to the peak within 10 ms from the start of
the AP. Onset latency of the IPSC was assessed as the
duration from the time of maximal rise rate of the presy-
naptic AP to the onset of the IPSC. Mean IPSC responses
shown and measured from at least 30 traces.
It should be noted that we have included reanalyzed data
(7 pairs) from a previous publication (Booker et al. 2013)
where we had measured and reported only the unitary IPSC
amplitudes for PV BC connections. We have assessed the
presynaptic properties of those synaptic connections toge-
ther with a set of newly recorded pairs (4 pairs) under
identical conditions.
Visualization, imaging and reconstruction
of the recorded neurons
Post hoc identification was performed on all recorded
neurons as previously described (Booker et al.
2013, 2014, 2017). Briefly, following successful outside-
out patch formation, slices were fixed in 4%
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB)
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overnight at 4 C. Slices were washed in PB and phosphate
buffered saline (PBS; 0.025 M PB ? 0.9% NaCl), then
blocked with 10% normal goat serum (NGS), 0.3–0.5%
TritonX-100, and 0.05% NaN3 all diluted in PBS at room
temperature (RT) for 1 h. Slices were then incubated in
primary antibodies for 48–72 h in a solution containing
5% NGS, 0.3–0.5% TritonX-100 and 0.05% NaN3in PBS
at 4 C. CCK BCs were identified with a primary antibody
recognizing CCK (Mouse monoclonal 1:5000, G. Ohning,
CURE, UCLA, CA, USA). PV BCs were identified using a
primary antibody against PV (mouse monoclonal,
SWANT, Marly, Switzerland; 1:5000; see Booker et al.
2013). Slices were washed in PBS and then incubated with
anti-mouse fluorescent secondary antibodies (goat anti-
mouse Alexa Fluor 546, 1:500; Invitrogen, Dunfermline,
UK) with fluorescently conjugated streptavidin (Alexa
Fluor 647; 1:500, Invitrogen) in a solution containing 3%
NGS, 0.1% TritonX-100 and 0.05% NaN3 at 4 C over-
night (O/N). Slices were then washed in PBS, then PB, and
mounted on glass slides with a 300 lm agar spacer, with a
polymerizing mounting medium (Fluoromount-G, South-
ern Biotech, AL, USA) and coverslipped.
Neurons were imaged using a confocal laser scanning
microscope (FluoView 1000, Olympus) with a 209 (N.A.
0.75) lens and z-axis stacks of images (4 Mpixel resolution,
1 lm z-steps) collected to allow identification of somato-
dendritic and axonal arborizations. Immunoreactivity of
recorded neurons was tested at the soma with a silicon-
immersion 609 (N.A. 1.3) objective lens. Neurons were
reconstructed offline from digitally stitched image stacks,
which were segmented and reconstructed using semi-au-
tomatic analysis software (Simple Neurite Tracer plug-in
for the ImageJ/FIJI software package; http://fiji.org; Lon-
gair et al. 2011).
Antibody characterization for immunogold labeling
The specificity of the affinity-purified antibodies to
CB1R (Fukudome et al. 2004), M2R (Alomone Labs,
Israel), GABAB1 (B17, Kulik et al. 2002; B62, Kulik
et al. 2006) were assessed with immunoblot analysis of
crude membrane fractions derived from either mouse
brains (CB1R and M2R) or rat brains (B17 and B62).
Single protein bands were detected with M2R and CB1R
antibodies, whereas GABAB1 antibodies gave rise to two
immunoreactive products with estimated molecular mas-
ses of 130 and 100 kDa, as expected from the two splice
variants of the GABAB1 subunit. In addition the band for
M2R was not detected in M2R knock-out brains (data
not shown). All antibodies used targeted the intracellular
epitopes of the transmembrane proteins and therefore
resulted in specific labelling on the protoplasmic face (P-
face) of the replicas.
SDS-digested freeze-fracture replica immunogold
labeling (SDS-FRL)
SDS-FRL was performed as previously described (Althof
et al. 2015). Briefly, 60-day-old Wistar rats (2) were per-
fusion fixed with 2% PFA and 15% saturated picric acid in
0.1 M PB. Transverse 100 lm hippocampal sections were
cut and cryoprotected O/N in PB with 30% glycerol at
4 C. Blocks containing the str. pyramidale and radiatum
of the CA1 area were blocked-out and then frozen by a
high-pressure freezing machine (HPM100, Leica, Austria).
Frozen samples were freeze-fractured at -140 C and
coated by deposition with carbon (5 nm), platinum (2 nm)
and carbon (18 nm) in a freeze-fracture replica device
(BAF 060, BAL-TEC, Lichtenstein). Replicas were
digested for 18 h at 80 C in a solution containing
2.5% SDS and 20% sucrose in 15 mM Tris buffered saline
(TBS) at pH 8.3. Replicas were then rinsed in washing
buffer [0.05% bovine serum albumin, (BSA) and 0.1%
Tween 20, in TBS] and blocked in a solution containing
5% BSA and 0.1% Tween 20 for 1 h at RT. Subsequently,
replicas were incubated in one of the following mixtures of
primary antibodies: (a) CB1R [Guinea pig (Gp); 1:3000,
Fukudome et al. 2004] and GABAB1 [B17, Rabbit (Rb);
5 lg/ml, Kulik et al. 2002], (b) M2R (Rb; 10 lg/ml, Alo-
mone Labs, Israel) and GABAB1 [B62, (Gp); 10 lg/ml,
Kulik et al. 2006] made up in 50 mM TBS containing 1%
BSA and 0.1% Tween 20 O/N at 4 C. Replicas were then
rinsed in TBS, blocked for 30 min and reacted with a
mixture of either (a) gold-coupled 10 nm goat anti-guinea
pig IgG and 5 nm goat anti-rabbit IgG or (b) 10 nm goat
anti-rabbit IgG and 5 nm goat anti-guinea pig IgG sec-
ondary antibodies (1:30; BioCell Research Laboratories,
Cardiff, UK) diluted in TBS containing 1% BSA and 0.1%
Tween 20 for 3 h at RT or at 4 C O/N. Replicas were
subsequently rinsed in TBS, ultrapure water and then
mounted on 100-mesh grids. Quantitative analysis was
performed at 6000–10,0009 magnification under an elec-
tron microscope (Philips CM100). Images were taken with
a CCD camera (Orius SC600, GATAN, Inc.) and acquired
with GATAN software. Presynaptic axon terminals were
collected in str. pyramidale and identified as perisomatic
due to their direct apposition to a somatic or very proximal
dendritic membranes. Putative CA1 PC spiny dendrites
were collected from str. radiatum as positive control.
Immunogold particle density was calculated by counting
the number of particles on the 2D surface of identified axon
terminals and dendrites using the FIJI software package.
Statistical analysis
Statistical analysis was performed with Graphpad Prism
3.0 (GraphPad Software, CA, USA). Group data were
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compared with one-way ANOVA tests, combined with
Bonferroni post-test to establish group differences. Anal-
ysis of unpaired and paired data was performed with
Mann–Whitney or Wilcoxon matched-pairs tests, respec-
tively. Data are shown as mean ± SEM throughout. Sta-
tistical significance was assumed if P\ 0.05.
Results
Presynaptic GABABRs differentially inhibit
CB1R- and M2R-sensitive perisomatic inhibitory
transmission
To assess the role of presynaptic GABABRs in pharma-
cologically identified putative CCK versus PV BC axon
terminals, we first recorded monosynaptic IPSCs evoked
by minimal stimulation from CA1 PCs (15 cells) in the
presence of ionotropic glutamate receptor blockers
(NBQX: 10 lM and APV: 50 lM). All CA1 PCs were
morphologically identified, as previously described (Degro
et al. 2015), and had a soma in str. pyramidale with a single
large caliber apical dendrite projecting through str. radia-
tum, with all dendrites decorated with dendritic spines.
Stimulation via electrodes placed in the str. pyramidale, in
close proximity to the recorded PCs (10–20 lm distal)
consistently produced fast IPSCs. To identify CB1R-sen-
sitive responses, corresponding to putative CCK BC
afferents, brief (2 min) bath application of the highly
potent receptor agonist WIN-55212 (WIN; 1 lM) was
performed. In ten cells, this brief application of WIN
reduced the IPSC amplitude to 58.3 ± 15.7% (P = 0.002,
Wilcoxon matched-pairs test, Fig. 1a) confirming the
presence of CB1R on the stimulated axons in this subset of
recordings. Following complete washout of WIN and full
recovery of the IPSCs to control levels, the selective
GABABR agonist baclofen was bath applied (10 lM,
5 min) resulting in a large decrease in IPSC amplitude to
29.9 ± 5.5% of control (P = 0.0001, Wilcoxon matched-
pairs test, Fig. 1a, c, e). In addition, there was an outward
IWC induced in the recorded PCs (95.6 ± 12.0 pA;
P = 0.001) consistent with GABABR-mediated activation
of a postsynaptic potassium current (Booker et al.
2013, 2017; Fig. 1a, middle). Both the IPSC amplitude and
IWC were fully recovered to control levels with the sub-
sequent removal of baclofen and application of the potent
and selective GABABR antagonist CGP-55845 (CGP;
5 lM).
In five recorded PCs, WIN application had no inhi-
bitory effect on the IPSC amplitude (Fig. 1b). In these
WIN-insensitive afferents, bath application of baclofen
reduced the IPSC amplitude only to 61.5 ± 11.3% of
control (P = 0.04), indicating an approximately twofold
weaker inhibition than for WIN-sensitive afferents
(P = 0.024, Mann–Whitney test, Fig. 1b, d, e). Similar
to the recordings for CB1R-sensitive afferents, baclofen
application induced a postsynaptic outward IWC of
83.7 ± 18.3 pA in the postsynaptic PCs (compared to
control: P = 0.02; CB1R-insensitive versus -sensitive:
P = 0.75, Mann–Whitney test). To confirm that the
CB1R-insensitive afferents corresponded to M2R-con-
taining putative PV BC axons, we subsequently bath
applied the selective agonist ABET (10 lM, 5 min).
Indeed, in response to ABET application, IPSC ampli-
tude was reduced in all five recorded PCs to
51.2 ± 14.4% of control. Neither WIN nor ABET
application resulted in significant change in holding
current of the recorded neurons, indicating a predomi-
nantly presynaptic locus of activity under these recording
conditions (WIN: P = 0.89; ABET: P = 0.66; Wilcoxon
signed rank tests). These data indicate that both popu-
lations of pharmacologically identified CA1 BC axon
terminals contain functional GABABRs, but are differ-
entially inhibited by these autoreceptors.
Strong presynaptic GABABR-mediated inhibition
at the synaptic output of CCK BCs
Our previous recordings of synaptically coupled PV BC
and PC pairs were consistent with the results of the
minimal stimulation experiments and indicated an
approximately 40% (of control) reduction in the unitary
IPSCs during application of baclofen (10 lM; Booker
et al. 2013, Fig. 7). To directly assess the effects of
GABABR activation on GABA release from CCK BCs,
we performed paired recordings between identified CCK
BCs and CA1 PCs (Fig. 2a). Interneurons were
anatomically identified following overnight fixation,
visualization of biocytin and immunolabeling with CCK
antibodies. CCK BCs were identified based on the
presence of dense axon in and near the str. pyramidale,
forming ring like ‘‘baskets’’ around the somata of puta-
tive CA1 PCs (Fig. 2).
In dual recordings from eight synaptically coupled CCK
BC to CA1 PC pairs, APs (29 with 50 ms interval) evoked
in the CCK BCs were reliably followed by short-latency
unitary IPSCs in the CA1 PCs (Fig. 2b, upper), with an
average amplitude of 29.2 ± 9.3 pA of first IPSC and
failure rate of 35.1 ± 8.9%. The second IPSCs showed
marked paired-pulse depression (PPD) with a ratio of
0.47 ± 0.05. Consistent with a relatively low temporal
precision of release at these synapses (Hefft and Jonas
2005), the coefficient of variation (CV) of the onset latency
was 0.52 ± 0.12 (Fig. 2c–h). Bath application of 10 lM
baclofen significantly reduced the average amplitude of the
first IPSCs to 17.6 ± 6.1% to 4.8 ± 2.5 pA (P = 0.02,
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repeated measures 1-way ANOVA). In fact, the reduction
here was comparable to that observed in the minimal
stimulation experiments for WIN-sensitive afferents
(P = 0.19, Mann–Whitney test). Application of CGP
(5 lM) resulted in a full recovery of the IPSC amplitude
(Fig. 2b, c). Consistent with a presynaptic locus of
GABABR activity, baclofen application resulted in an
increase in failure rate to 76.6 ± 8.6% (P\ 0.0001,
repeated measures 1-way ANOVA) and enhanced PPD to
0.24 ± 0.08 (P = 0.02, repeated measures 1-way
ANOVA). Furthermore, the CV of onset latency decreased
to 0.32 ± 0.12 (P = 0.03, repeated measures 1-way
ANOVA).
Given the apparent differences in the degree of presy-
naptic inhibition between CCK and PV BC-mediated
transmission, we next performed paired recordings from
PV BCs (4 cells) to further characterize these effects. PV
BCs were all identified on the basis of PV immunoreac-
tivity and axon collaterals localized to str. pyramidale
(Supplementary Fig. 1) as previously described (Booker
Fig. 1 Presynaptic GABABRs inhibit transmission at CB1R-express-
ing perisomatic GABAergic terminals more strongly than M2R-
positive terminals. a Representative WIN-sensitive IPSCs in a CA1
PC evoked by minimal stimulation delivered to the CA1 str.
pyramidale (top traces) under control conditions (Ctrl) and during
sequential bath application of WIN-55212 (WIN, 1 lM, 2 min),
baclofen (Bac, 10 lM, 5 min) and CGP-55845 (CGP, 10 lM, 5 min);
control trace is underlain for all conditions for comparison. Time-
course plots of the mean IWC (middle) and normalized amplitude of
the WIN-sensitive IPSCs recorded from 10 CA1 PCs (bottom).
b Effects of baclofen application on WIN-insensitive IPSCs presented
as in a. These IPSCs were consistently inhibited by subsequent
application of the selective M2R agonist, ABET (10 lM, 5 cells).
Summary bar charts of the mean IPSC amplitudes elicited by WIN-
sensitive (c) and insensitive afferents (d) measured at the end of each
pharmacological epoch. Numbers of recorded PCs indicated in
brackets. e Bar chart of the normalized IPSC amplitudes elicited by
WIN-sensitive (WIN ?ve) and insensitive afferents (WIN-ve)
during Bac and CGP application. Statistics shown: ns P[ 0.05,
* P\ 0.05, *** P\ 0.001, Mann–Whitney or Wilcoxon signed rank
tests, corrected for multiple comparisons
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et al. 2013). Interestingly, this new sample included not
only examples of BCs with vertically arranged dendrites
spanning all layers, but also a horizontally oriented somato-
dendritic domain confined to the str. oriens (Supplemen-
tary Fig. 1D). In all these PV BCs to CA1 PC paired
recordings we observed a baclofen-produced inhibition of
IPSC amplitude to 45.0 ± 5.1% of control levels, which
recovered to control levels after the application of CGP
(Fig. 2g). Thus, the presynaptic inhibitory effects in these
pairs were markedly smaller than that observed for CCK
BCs, but corresponded well to our previously published
data (seven cells; 57.1 ± 0.4% of control; P = 0.49;
Booker et al. 2013). As we had previously only analyzed
the IPSC amplitude difference, we now reanalyzed these
previously published cells for PPD and failure rate and
included them with these four additional paired recordings
(Fig. 2g–j). For the pooled PV BC data set (11 cells),
GABABR-mediated presynaptic inhibition reduced IPSC
amplitude to 51.2 ± 6.0% of control levels (Fig. 2j), not
different from that observed in M2R-sensitive synapses in
Fig. 1 (P = 0.51, Mann–Whitney test), but reflecting a
substantially lower inhibition than in CCK–BC pairs
(P = 0.004, Mann–Whitney test). Analysis of IPSC failure
rate showed that in baseline conditions PV BCs had less
failures of transmission (22.4 ± 6.8%), which was not
significantly different from that of CCK BCs (P = 0.39).
However, during baclofen application PV BCs showed
only a very modest increase in IPSC failure rate to
33.8 ± 9.4%, which was not different from control
(P = 0.16, Wilcoxon signed rank test, Fig. 2h). Indeed, the
failure rate of PV BC in baclofen was substantially lower
than that of CCK BCs (P = 0.006, Mann–Whitney). Fur-
thermore, as expected from the high release probability of
PV BCs, they showed PPD (0.71 ± 0.05), which was
removed by application of baclofen to 1.02 ± 0.1
(P = 0.02, 1-way ANOVA with multiple comparisons).
Both the effect on IPSC amplitude and failure rate in PV
BCs was reversed by subsequent application of CGP.
Interestingly, unlike CCK BCs, CGP in PV BCs applica-
tion resulted in a stronger PPD than under control condi-
tions (0.54 ± 0.6, P = 0.025) suggesting that under
control conditions there might be a level of tonic effect of
GABABR on presynaptic short-term plasticity. These data
show that despite both populations of BCs express presy-
naptic GABABRs, the ability of these receptors to inhibit
GABA release onto CA1 PC somata is substantially dif-
ferent. Furthermore, CCK and PV BC synapses onto CA1
PCs show divergence in the effects of GABABR activation
on short-term plasticity and the failures of transmission.
In a subset of paired recordings, we found that the
presynaptic CCK IN had axon collaterals in str. radiatum
and oriens, targeting dendritic domains of CA1 PCs, con-
sistent with the Schaffer-Collateral Associated (SCA) type
(Booker et al. 2017). It is known that CCK SCA cells share
many of the same presynaptic properties of CCK BCs,
including CB1R sensitivity (Lee and Soltesz 2011), so we
next asked if CCK SCA cells also showed presynaptic
GABABR-mediated inhibition. In the six synaptically
coupled SCA to CA1 PC pairs (Fig. 3) we observed IPSCs
in response to presynaptic APs with an average amplitude
of 9.1 ± 7.0 pA (first IPSCs), which was reduced to
3.5 ± 1.5% of control following baclofen application
(Fig. 3b, c, f), similar to that observed in CCK BCs
(P = 0.13, Mann–Whitney test). IPSC amplitudes recov-
ered to close to control levels with application of CGP
(P = 0.06, Wilcoxon signed rank test). CCK SCA cells
had a failure rate of 44.1 ± 13.2%, which increased to
88.8 ± 6.4% upon baclofen application (P = 0.03, Wil-
coxon signed rank test, Fig. 3d). They showed a PPD of
0.56 ± 0.1, similar to that of CCK BCs (P = 0.28, Mann–
Whitney test), but unlike CCK BCs, in SCA cells the PPD
changed to facilitation with a ratio of 1.33 ± 0.32 upon
application of baclofen (P = 0.02, Mann–Whitney test,
Fig. 3e). However, in three SCA cells paired-pulse ratio
could not be measured following baclofen application due
to complete inhibition of the IPSC. Together, these data
suggest that dendritic inhibitory CCK SCA cells possess
similar presynaptic GABABR inhibition to their BC
counterparts, with potential divergence in its effect on
short-term plasticity.
Different surface densities of presynaptic GABABRs
at perisomatic synapses
To determine whether the differences in GABABR-medi-
ated presynaptic inhibition of BC terminals are due to
differential distribution pattern and/or density of functional
receptors we performed quantitative SDS-FRL electron
microscopy. Immunolabeling for the two marker receptors,
CB1R (Fig. 4a, b) and M2R (Fig. 4c, d), showed charac-
teristic labeling of putative presynaptic axon terminals in
str. pyramidale of CA1. Labeling for CB1R was consis-
tently stronger on a subset of perisomatic terminals, while
M2R-positive terminals showed generally weaker labeling.
When GABAB1 subunit localization was examined on
CB1R-positive terminals it was found that nearly all ter-
minals contained immunogold particles for GABAB1
(95.2% of terminals, 67 terminals) (Fig. 4a, b), whereas
only 40.6% of M2R-positive terminals (64 terminals)
showed immunoreactivity for GABAB1 (Fig. 4c, d), which
was significantly lower than on CB1R-positive terminals
(P\ 0.0001, Fisher exact test, Fig. 4e). We then asked
whether there was also a difference in the density of the
GABAB1 receptor subunit on terminals. In a subset of
CB1R-positive terminals, which all showed GABAB1
labeling (23 terminals), GABAB1 surface density was high
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at 20.6 ± 1.3 particles/lm2. This density was similarly
high to that of CA1 PC dendrites in str. radiatum
(17.0 ± 1.8 particles/lm2, 7 dendrites; P = 0.23, 1-way
ANOVA with multiple comparisons). Interestingly, on
M2R-containing axon terminals we observed a much
weaker GABAB1 labeling density at 4.5 ± 0.5 particles/
lm2 (38 axon terminals), which was substantially and
significantly lower than that of both CB1R-containing
terminals and CA1 PC dendrites (both P\ 0.0001, 1-way
ANOVA with multiple comparisons, Fig. 4f).
These data confirm that there are IN type-specific dif-
ferences in the presynaptic GABABR expression in inhi-
bitory axon terminals, as measured by the density of the
constitutive subunit GABAB1, between putative CCK and
PV BC. Interestingly, this data shows that not only is the
number of terminals that containing GABAB1 different, but
also the receptor density on those terminals is different,
plausibly explaining the differences we observed in
GABABR-mediated presynaptic inhibition between CB1R-
and M2R-containing synapses.
Discussion
Presynaptic neuromodulation is a central neuronal prop-
erty, which defines cell types as well as our understanding
of the role those cells play in local networks. Our results
demonstrate that while both CCK and PV BCs contain
presynaptic GABABRs at their axon terminals, acting as
autoreceptors, their surface density and inhibitory potential
at these two synapses show marked differences. We pro-
vide compelling evidence that virtually all CCK BC ter-
minals contain GABABRs at high levels and GABA release
is dramatically inhibited by their activation. In contrast,
only 40% of PV BC axon terminals express GABABRs at
detectable levels, leading to only a moderate reduction in
inhibitory transmission at these output synapses upon
GABABR activation. These findings add to an increasing
list of molecular and functional differences between these
two major IN types with implications for their network
function.
Presynaptic GABABRs as auto- and heteroreceptors
Presynaptic control of synaptic transmission by GABABRs
has been established for various transmitter systems,
including glutamatergic and GABAergic transmission
(Bowery et al. 1981; Connors et al. 1988; Deisz and Prince
1989). Accordingly, the robust inhibitory effect of
GABABRs as presynaptic autoreceptors at GABAergic
synapses has been well documented in diverse brain
regions including the neocortex and hippocampus (Misgeld
et al. 1984; Peet and McLennan 1986; Ola´h et al. 2009).
However, while divergence in the sensitivity to GABABR-
mediated heterosynaptic inhibition at major glutamatergic
pathways have been long recognized in the forebrain
(Lanthorn and Cotman 1981; Ault and Nadler 1983;
Molyneaux and Hasselmo 2002), little is known of
GABABRs in diverse INs types, let alone the differential
nature of this. Prior in situ and immunocytochemical
studies suggested that GABABRs are present at high levels
in somata of some, but not all interneuron types (Fritschy
et al. 1999; Sloviter et al. 1999). In fact, for postsynaptic
compartments our recent results demonstrated that mor-
phological subtypes of PV and CCK INs show substantial
differences in GABABR surface density, as well as in the
postsynaptic currents (Booker et al. 2013, 2017). Further-
more, at the presynaptic level, dendritic- and perisomatic-
targeting PV IN subtypes were found to be sensitive to
GABABR-mediated inhibition at their output synapses,
albeit differentially (Booker et al. 2013). For perisomatic
synapses formed by putative BCs, earlier electrophysio-
logical investigations using minimal stimulation indicated
that GABABRs modulate GABA release at most, but not all
bFig. 2 Unitary IPSCs produced in CA1 PCs by identified CCK and
PV BCs show differential presynaptic GABABR-mediated inhibition.
a Reconstruction of a synaptically coupled CCK BC (soma and
dendrites in black, axon in red) and CA1 PC (soma and dendrites in
blue) pair. Inset, top, voltage responses elicited in the CCK BCs and
the CA1 PCs to hyper- to depolarizing current steps (-500 to 500 pA,
50 pA steps, 500 ms duration). Note the regular-spiking phenotype of
the CCK BCs. Inset, right, immunolabeling for CCK (in green
pseudocolor) in the biocytin-filled soma of the BC (in gray). Pyr.,
stratum pyramidale; Ori., stratum oriens; Rad., stratum radiatum;
L-M, stratum lacunosum-moleculare. b upper, representative pairs of
action potentials elicited in the same CCK BC as in a (upper traces,
suprathreshold current pulses of 1–2 nA, 1 ms duration, 50 ms
interval) resulted in unitary IPSCs in the post-synaptic CA1 PC (lower
traces) under control conditions (left panel), followed by sequential
bath application of baclofen (10 lM, middle panel), and CGP
(10 lM; right panel); baclofen and CGP traces are underlain by
control traces (gray). b lower, Time-course plot of the postsynaptic
whole-cell current (IWC; top) and unitary IPSC amplitude (lower)
from the same CCK BC–CA1 PC pair over the course of the
experiment, including the initial control conditions and following
application of baclofen and then CGP to the bath. Summary bar charts
of synaptic parameters for CCK BC–CA1 PC pairs (8 cells) under
control conditions and during baclofen and CGP bath application:
IPSC amplitude (c), apparent failures of transmission (d), paired-
pulse ratio (e) and latency distribution (CV, f). g–i Bar charts of
synaptic parameters for PV BC–CA1 PC pairs (11 cells) under control
conditions, baclofen and CGP application: IPSC amplitude (g), failure
rate of IPSCs (h) and the paired-pulse ratio (i). j Summary bar chart
of the normalized IPSC amplitudes for a comparison of baclofen-
induced inhibition at CCK and PV BC synapses. CGP recovery is
shown for both cell types. Statistics shown: ns P[ 0.05, * P\ 0.05,
** P\ 0.01, *** P\ 0.001, results from repeated measures
ANOVA with Sidak’s multiple comparison test or Mann–Whitney
tests (j), all data is derived from 8 CCK BC/CA1 PC and 11 PV BC/
CA1 PC pairs
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axon terminals (Lambert and Wilson 1993). Consistent
with these findings the present anatomical results show that
individual perisomatic inhibitory axon terminals contain
variable levels of the receptor depending on their
neurochemical identity: CCK-positive terminals have
consistently high densities, whereas PV-positive axon ter-
minals show a dichotomy with one half of them containing
an approximately four-times lower density and the other
Fig. 3 Identified CCK SCA cells show strong presynaptic GABABR-
mediated inhibition. a Reconstruction of a synaptically coupled CCK
SCA (soma and dendrites in black, axon in red) and a CA1 PC (soma
and dendrites in blue, axon in green). Inset (top), voltage responses
elicited in the CCK SCA cells and the CA1 PCs to hyper- to
depolarizing current steps (-500 to 500 pA, 50 pA steps, 500 ms
duration). Inset (right), immunolabeling for CCK (in green pseudo-
color) in the soma of the SCA cell (in gray). Pyr., stratum
pyramidale; Ori., stratum oriens; Rad., stratum radiatum. b, upper,
Representative pairs of action potentials elicited in the SCA cell
shown in a (upper traces, suprathreshold current pulses of 1–2 nA,
1 ms duration, 50 ms interval) were followed by short-latency IPSCs
in the recorded CA1 PC (lower traces) under control conditions (left
panel), during bath application of baclofen (10 lM, middle panel),
and CGP (10 lM; right panel); baclofen and CGP are underlain by
control traces (gray). b, lower, time-course plot of the postsynaptic
whole-cell current (IWC; top) and unitary IPSC amplitude (lower)
from the same CCK SCA cell–CA1 PC pair during the experiment,
including control period, and subsequent baclofen and CGP applica-
tions. Summary bar charts of synaptic properties of CCK SCA–CA1
PC pairs (six pairs) during each pharmacological epoch: IPSC
amplitude (c), apparent failures of transmission (d) and paired-pulse
ratio (PPR, e). f Summary bar chart of the normalized IPSC
amplitudes during baclofen and CGP applications in CCK SCA cells.
Statistics shown: ns P[ 0.05, * P\ 0.05, ** P\ 0.01, results from
Wilcoxon signed rank tests, all data are derived from 6 CCK SCA–
CA1 PC pairs
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half being negative for GABABRs. In good agreement, our
data obtained by minimally stimulation and paired
recordings converges, demonstrating that GABABR acti-
vation markedly reduces transmission at CCK output
synapses (Neu et al. 2007; Lee and Soltesz 2011; Booker
et al. 2013; Jappy et al. 2016), but has an approximately
twofold weaker effect at PV synapses at the concentration
of baclofen used in our experiments. In contrast to the
findings of Lambert and Wilson (1993), however, all
putative PV axons and identified unitary connections were
affected to a similar degree and no baclofen insensitive
connections were found. These electrophysiological find-
ings suggest that the molecular dichotomy observed at the
level of the individual axon terminals in the electron
microscopic level (see Fig. 4) affects the multiple synaptic
contacts formed between individual pre- and postsynaptic
neurons (Buhl et al. 1994; Bartos et al. 2001) in a stochastic
manner. What trafficking mechanisms can maintain such a
homogeneous distribution of dichotomy in individual
axons remains an interesting open question.
Molecular and functional dichotomy of BC synapses
GABAergic INs show a high level of diversity, plausibly
reflecting their functional specification in cortical circuits.
In good agreement with this concept, the two BC types
show striking differences in their anatomical, physiological
and molecular properties (Freund and Katona 2007; Arm-
strong and Soltesz 2012). Axon terminals of CCK and PV
BCs differ in their complementary expression of VGCCs at
the active zone (Cav2.2 versus Cav2.1 types, respectively)
and presynaptic neuromodulatory receptors (CB1R versus
M2R and l-opioid receptors, respectively) (Hefft and Jonas
2005; Neu et al. 2007; Lee and Soltesz 2011; Jappy et al.
2016). While both CCK and PV BCs express GABAB
autoreceptors at their output synapses (Neu et al. 2007; Lee
and Soltesz 2011; Booker et al. 2013), our results now
demonstrate that their expression and functional impact is
quantitatively different between the two types. The strong
presynaptic inhibitory action mediated by GABABRs at
CCK synapses is consistent with previous findings that
Fig. 4 Surface expression of GABAB1 differs on CB1R- and M2R-
positive axon terminals. a, b Electron micrographs of CB1R-positive
(10 nm gold particles) putative CCK BC axon terminals (b) forming
synapses either with somata (S in A) or proximal dendritic shafts (den
in B) of putative CA1 PCs. Note, that CB1R-positive terminals show
consistently high levels of immunogold labeling for GABAB1 (5 nm,
arrows) (synaptic vesicles are indicated by arrowheads in a). c,
d Electron micrographs of M2R-positive (10 nm immunogold)
putative PV BC axon terminals (b) contacting somata (S) of putative
CA1 PCs. M2R-positive terminals showed a lower GABAB1 density
(5 nm particles, arrows in c) and also included immunonegative
terminals (b in d). Insets in a–c show differences in particle size, with
small 5 nm gold particles for GABAB1 (arrows) and the larger 10 nm
particles for the interneuron-specific marker CB1R and M2R,
respectively. e Summary bar chart of the proportion of GABAB1 on
double-labeled CB1R- or M2R-containing axon terminals. The total
number of examined CB1R- and M2R-immunopositive terminals is
indicated in parenthesis. f Quantification of the surface density of
immunogold particles for GABAB1 subunit on CB1R- and M2R-
positive axon terminals (with GABAB1 immuno-negative profiles
exclude) in comparison to PC dendrites. Note the divergence of
labeling density between CB1R- and M2R-positive terminals. Statis-
tics shown: ns P[ 0.05, *** P\ 0.0001, Fisher’s exact test and
1-way ANOVA with multiple comparisons. Scale bars 200 nm
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transmission is reduced by 70–100% in the presence of
baclofen in a concentration range of 1–100 lM (Neu et al.
2007; Lee and Soltesz 2011; Jappy et al. 2016). This strong
presynaptic autocrine modulation converges with the sim-
ilarly strong retrograde control, exerted by the endo-
cannabinoids system via CB1R (Katona et al. 1999; Neu
et al. 2007; Lee and Soltesz 2011; Jappy et al. 2016). The
effect of GABABR activation at PV BC synapses, in con-
trast, is substantially smaller; however, our data is not
consistent with a general lack of GABABR at these
synapses as assumed earlier (Freund and Katona 2007).
In addition to the changes in the amplitude and relia-
bility of ISPCs, baclofen has differential effects on the
dynamic behavior of CCK and PV synapses: PPD observed
at PV output synapses was fully abolished by the drug and
recovered by subsequent application of the selective
antagonist CGP. This finding is in good agreement with
previous observations that GABABR activation eliminates
short-term depression at both excitatory and inhibitory
synapses in the hippocampus and can thereby maintain
synaptic transmission during repeated activation albeit at
reduced amplitudes (Lei and McBain 2003). Surprisingly,
PPD observed at CCK BC synapses was not reduced but
enhanced in the presence of baclofen, which also recovered
to control levels in CGP. These results are incompatible
with a tonic control of perisomatic inhibitory transmission
or a direct involvement of these receptors in frequency
dependent behavior at the time scales investigated. Rather,
our observations plausibly reflect indirect effects due to the
modulation of release machinery and the probability of
GABA release (Dittman et al. 2000; Lei and McBain
2003).
Finally, perisomatic CCK synapses differ in their long-
term plasticity: while theta-burst stimulation induces typi-
cally LTP at inhibitory synapses, the output synapses of
CCK interneurons display LTD. Although the induction of
LTD requires activation of postsynaptic GABABRs with an
inhibitory effect on adenyl cyclase and PKA activity
(Jappy et al. 2016), it remains open what is the contribution
of the highly expressed presynaptic receptors.
Functional implications of the dichotomy
of perisomatic synapses
While the two BC types converge on the perisomatic
compartment of their postsynaptic targets, their distinct
properties and activity patterns in vitro and in vivo reflect
distinct functions in the network. A differential contribu-
tion of the two types to network activity patterns is well
established (Klausberger and Somogyi 2008): CCK BCs
integrate incoming inputs over longer time scales and
discharge and release GABA with low temporal precision,
mediating a tonic form of inhibition to their targets (Hefft
and Jonas 2005; Daw et al. 2009; Cea-del Rio et al. 2011).
Activation of presynaptic GABABRs could therefore sub-
stantially suppress CCK BC output, resulting in dynamic
disinhibition of principal cells, enhanced network activity
and facilitation of long-term potentiation among principal
cells (Davies et al. 1991; Mott and Lewis 1991). In con-
trast, PV BCs are proposed to act as fast-signaling devices
and contribute to the generation of fast oscillations at
gamma and ripple frequencies (Jonas et al. 2004; Bartos
et al. 2007; Sohal et al. 2009). Enhanced GABABR-medi-
ated presynaptic inhibition at PV BC synapses during
network activity (Scanziani 2000) may dampen, but will
not abolish the entrainment of target cell populations, due
to its moderate effect on IPSC amplitudes and the removal
of PPD.
Beyond these physiological network functions, evidence
is mounting for significant role for presynaptic GABABRs
in the aetiology of neuropathological disorders, notably
epilepsy and intellectual disabilities (i.e. Fragile X syn-
drome). In epilepsy, while a selective decrease of CCK BC
terminals have been observed in the CA1 (Wyeth et al.
2010), GABABRs expression at CCK axon terminals
appears to be increased leading to stronger disinhibitory
effects of principal cells potentially promoting seizure
generation and the progression of epilepsy (Dugladze et al.
2013). Interestingly, a similar hypersensitivity of
GABABR-mediated presynaptic inhibition of feedforward
inhibition was observed in a mouse model of Fragile X
syndrome (Wahlstrom-Helgren and Klyachko 2015).
While, the IN subtype involved was not identified in these
experiments, neurogliaform and CCK interneurons are
likely candidates due to their high expression of the
receptors. The increased presynaptic sensitivity leads to an
altered excitation/inhibition balance in the network, which
is thought to be an underlying circuit mechanism of cog-
nitive impairments observed both in patients and animal
models (Silverman et al. 2015; Wahlstrom-Helgren and
Klyachko 2015).
In conclusion, we provide the first direct comparative
and quantitative data showing that presynaptic GABABRs
exert differential inhibition at CCK and PV BC synapses,
resulting from a higher surface expression of the receptor at
all CCK BC terminals and a lower protein density present
in a subpopulation of boutons of PV BCs. These data
provide further evidence that distinguishes these two major
IN types with respect to their presynaptic molecular com-
position and physiological functions.
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